345 (PB125) - STC-15, an oral small molecule inhibitor of the RNA methyltransferase METTL3, inhibits tumour growth through activation of anti-cancer immune responses associated with increased interferon signalling, and synergises with T cell checkpoint blockade
| Autor: | Ofir-Rosenfeld, Y., Vasiliauskaitė, L., Saunders, C., Sapetschnig, A., Tsagkogeorga, G., Albertella, M., Carkill, M., Self-Fordham, J., Holz, J.B., Rausch, O. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S123-S123 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect